Shengchao Lin

608 total citations
12 papers, 497 citations indexed

About

Shengchao Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Shengchao Lin has authored 12 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Shengchao Lin's work include Photodynamic Therapy Research Studies (3 papers), Cancer therapeutics and mechanisms (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Shengchao Lin is often cited by papers focused on Photodynamic Therapy Research Studies (3 papers), Cancer therapeutics and mechanisms (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Shengchao Lin collaborates with scholars based in China and Japan. Shengchao Lin's co-authors include Jianwen Liu, Liyan Yang, Xin Liang, Lingling Zhang, Yuanhong Zheng, Kecheng Lei, Hongkun Wu, Norio Nagao, Zujun Que and Lin Zhou and has published in prestigious journals such as British Journal of Cancer, The International Journal of Biochemistry & Cell Biology and FEBS Journal.

In The Last Decade

Shengchao Lin

12 papers receiving 494 citations

Peers

Shengchao Lin
Guoli Wei China
Zujun Que China
Qihua Xu China
Xinlan Lu China
Min Kong China
Ye Yu China
Jiwei Ma China
Shengchao Lin
Citations per year, relative to Shengchao Lin Shengchao Lin (= 1×) peers Guanhua Du

Countries citing papers authored by Shengchao Lin

Since Specialization
Citations

This map shows the geographic impact of Shengchao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengchao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengchao Lin more than expected).

Fields of papers citing papers by Shengchao Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengchao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengchao Lin. The network helps show where Shengchao Lin may publish in the future.

Co-authorship network of co-authors of Shengchao Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shengchao Lin. A scholar is included among the top collaborators of Shengchao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengchao Lin. Shengchao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lin, Shengchao, Yu Zhang, Jun Yao, et al.. (2024). DB-1314, a novel DLL3-targeting ADC with DNA topoisomerase I inhibitor, exhibits promising safety profile and therapeutic efficacy in preclinical small cell lung cancer models. Journal of Translational Medicine. 22(1). 766–766. 9 indexed citations
2.
Lin, Shengchao, et al.. (2017). Endoplasmic reticulum-targeting photosensitizer Hypericin confers chemo-sensitization towards oxaliplatin through inducing pro-death autophagy. The International Journal of Biochemistry & Cell Biology. 87. 54–68. 49 indexed citations
3.
Liang, Xin, Liyan Yang, Shengchao Lin, et al.. (2017). Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells. British Journal of Cancer. 116(7). 903–911. 26 indexed citations
4.
Lei, Kecheng, Shengchao Lin, Liyan Yang, et al.. (2016). 3B, a novel photosensitizer, inhibits glycolysis and inflammation via miR-155-5p and breaks the JAK/STAT3/SOCS1 feedback loop in human breast cancer cells. Biomedicine & Pharmacotherapy. 82. 141–150. 28 indexed citations
5.
Zhou, Lin, Xin Liang, Lingling Zhang, et al.. (2016). MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2. Oncotarget. 7(32). 51943–51954. 111 indexed citations
6.
Yang, Liyan, Shengchao Lin, Kecheng Lei, et al.. (2016). Targeted deletion of miR‐139‐5p activates MAPK, NF‐κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer. FEBS Journal. 283(8). 1438–1452. 56 indexed citations
7.
Lei, Kecheng, Shaoying Tan, Yichun Xu, et al.. (2015). 3B, a novel of photosensitizer, exhibited anti-tumor effects via mitochondrial apoptosis pathway in MCF-7 human breast carcinoma cells. Tumor Biology. 36(7). 5597–5606. 13 indexed citations
8.
Lin, Shengchao, Kecheng Lei, Liyan Yang, et al.. (2015). Enhancement of oxaliplatin sensitivity in human colorectal cancer by hypericin mediated photodynamic therapy via ROS-related mechanism. The International Journal of Biochemistry & Cell Biology. 71. 24–34. 38 indexed citations
9.
Yang, Liyan, Shengchao Lin, Yueqi Li, et al.. (2015). The loss of MiR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling. The International Journal of Biochemistry & Cell Biology. 69. 153–161. 32 indexed citations
10.
Lin, Shengchao, et al.. (2015). Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE−/−Mice Induced by Hyperlipaemia. Evidence-based Complementary and Alternative Medicine. 2015. 1–8. 32 indexed citations
11.
Lin, Shengchao, et al.. (2014). Development of a multifunctional luciferase reporters system for assessing endoplasmic reticulum-targeting photosensitive compounds. Cell Stress and Chaperones. 19(6). 927–937. 12 indexed citations
12.
Zheng, Yuanhong, Zujun Que, Lingling Zhang, et al.. (2014). Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO. Journal of Cancer Research and Clinical Oncology. 140(11). 1883–1890. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026